If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJPM.L Regulatory News (JPM)

  • There is currently no data for JPM

Form 8.3 - Vantiv Inc.

5 Jul 2017 15:10

RNS Number : 2302K
Northern Trust Corporation
05 July 2017
 

 FORM 8.3

 

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

Rule 8.3 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Identity of the person whose positions/dealings are being disclosed:

Northern Trust Group

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

Vantiv Inc.

(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:

 

 

(e) Date position held/dealing undertaken:

4th July 2017

 

(f) Has the discloser previously disclosed, or are they today disclosing, under the Code in respect of any other party to this offer?

YES

JPMorgan Chase Bank and Worldpay Group PLC

 

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

 

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

 

Class of relevant security:

 

Common Stock

 

 

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

260,301.00

 

0.16

(2) Derivatives (other than options):

(3) Options and agreements to purchase/sell:

 

TOTAL:

260,301.00

 

0.16

 

 

All interests and all short positions should be disclosed.

 

Details of any open derivative or option positions, or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

(b) Rights to subscribe for new securities (including directors' and other executive options)

 

Class of relevant security in relation to which subscription right exists:

Details, including nature of the rights concerned and relevant percentages:

 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

 

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

 

(a) Purchases and sales

 

Class of relevant security

Buy/Sell

Quantity

Price ($)

 

 (b) Derivatives transactions (other than options)

 

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

 

(c) Options transactions in respect of existing securities

 

(i) Writing, selling, purchasing or varying

 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

 

(ii) Exercising

 

Class of relevant security

Product description

e.g. call option

Number of securities

Exercise price per unit

 

 

 

(d) Other dealings (including subscribing for new securities)

 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

 

 

 

The currency of all prices and other monetary amounts should be stated.

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

4. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

(c) Attachments

 

Is a Supplemental Form 8 (Open Positions) attached?

No

 

 

 

Date of disclosure:

5th July 2017

Contact name:

Alexandra Marshall-Grant

Telephone number:

020 7982 1844

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service and must also be emailed to the Takeover Panel at monitoring@disclosure.org.uk. The Panel's Market Surveillance Unit is available for consultation in relation to the Code's dealing disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RETUVRSRBWABRAR
Date   Source Headline
24th Apr 20175:30 pmRNSHolding(s) in Company
21st Apr 20177:00 amRNSDirector/PDMR Shareholding
20th Apr 20175:20 pmRNSHolding(s) in Company
20th Apr 201710:00 amBUSJPMorgan Chase Commits $8.6 Million to Fill Well-Paying, High-Demand Healthcare Jobs
20th Apr 20177:00 amRNSDirector/PDMR Shareholding
19th Apr 20175:20 pmRNSHolding(s) in Company
19th Apr 201711:15 amRNSHolding(s) in Company
18th Apr 20175:53 pmRNSPublication of Supplementary Prospectus
18th Apr 20175:04 pmRNSHolding(s) in Company
18th Apr 20173:37 pmRNSHolding(s) in Company
18th Apr 20177:00 amBUSJPMorgan Chase Declares Preferred Stock Dividend
13th Apr 20174:41 pmRNSJPMC&Co. Form 8-K dated Apr 13, 2017 (1Q presentn)
13th Apr 201712:02 pmRNSJPMC&Co. Form 8-K dated Apr 13, 2017 (1Q earnings)
13th Apr 201711:53 amBUSJPMorgan Chase Reports First-Quarter 2017 Financial Results
12th Apr 20179:14 amRNSNotice of Amendment
12th Apr 20179:08 amRNSNotice of Amendment
12th Apr 20179:03 amRNSNotice of Amendment
11th Apr 20177:00 amRNSDirector/PDMR Shareholding
7th Apr 20177:00 amRNSJPMC&Co. 2017 Proxy Statement
6th Apr 20177:00 amRNSDirector/PDMR Shareholding
6th Apr 20177:00 amBUSJPMorgan Chase 2017 Proxy Statement
5th Apr 20177:00 amBUSJPMorgan Chase Announces Adjustment to Warrant Exercise Price
4th Apr 20175:17 pmBUSJPMorgan Chase 2016 Annual Report
4th Apr 201710:09 amRNSHolding(s) in Company
3rd Apr 20175:01 pmBUSJPMorgan Chase First-Quarter 2017 Earnings
29th Mar 20175:19 pmBUSCity First Enterprises and 11th Street Bridge Park Receive $250,000 Investment from JPMorgan Chase & Co.
23rd Mar 20177:00 amRNSHolding(s) in Company
22nd Mar 20174:56 pmRNSHolding(s) in Company
22nd Mar 20177:00 amRNSDividend Declaration
22nd Mar 20177:00 amBUSJPMorgan Chase Declares Common Stock Dividend
21st Mar 20178:29 amRNSHolding(s) in Company
16th Mar 20172:47 pmBUSMacomb Innovation Fund Awards $75,000 to Three Detroit-Area Technology Startups
16th Mar 20171:42 pmRNSAmendment Notice
16th Mar 20171:38 pmRNSAmendment Notice
16th Mar 20171:37 pmRNSAmendment Notice
16th Mar 20171:30 pmRNSAmendment Notice
16th Mar 20171:29 pmRNSAmendment Notice
16th Mar 20171:25 pmRNSAmendment Notice
16th Mar 20179:24 amRNSHolding(s) in Company
16th Mar 20177:00 amBUSJPMorgan Chase Declares Preferred Stock Dividend
7th Mar 20177:00 amRNSRedemption Notice Notes due 2037 (XS0295264948)
3rd Mar 20177:00 amRNSDirector/PDMR Shareholding
1st Mar 20176:10 pmRNSPublication of Supplementary Prospectus
1st Mar 20177:00 amRNSJPMC&Co. Form 10-K;JPMCB 2016 Financial Statements
28th Feb 201711:56 amBUSJPMorgan Chase 2017 Investor Day
23rd Feb 201711:00 amBUSJPMorgan Chase Commits More Than $1.2 Million to Help Revitalize Detroit’s Neighborhoods
23rd Feb 20179:36 amRNSHolding(s) in Company
16th Feb 20177:00 amRNSDirector/PDMR Shareholding
14th Feb 20177:00 amBUSJPMorgan Chase Declares Preferred Stock Dividend
7th Feb 20174:05 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.